Skip to main navigation
  • Overview
  • Press Releases
  • Events & Presentations
    • Upcoming Events
    • Past Events
    • Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Documents & Charters
  • Financial Information
  • Stock Information
    • Stock Quote & Chart
    • Historical Price
    • Investment Calculator
  • Shareholder Services
    • Investor FAQs
    • Document Request
    • Contact IR
  • Back to CRISPR »

Press Releases

Press Releases

Keyword Search

Apr 10, 2021

CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function

Apr 06, 2021

CRISPR Therapeutics to Participate in the 20th Annual Needham Virtual Healthcare Conference

Mar 10, 2021

CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2021 Annual Meeting

Mar 03, 2021

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Feb 16, 2021

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

Feb 05, 2021

CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day

Feb 01, 2021

CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer


Shareholder Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR

Interested in joining our team? Careers at CRISPR

© 2021 CRISPR Therapeutics. Contact | Privacy Policy | Terms and Conditions